| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/23/2003 | WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions |
| 10/23/2003 | WO2002090583A3 Skin treatment |
| 10/23/2003 | WO2002088747A3 Biopolymer marker having a molecular weight of 1845 daltons |
| 10/23/2003 | WO2002088731A3 Biopolymer marker having a molecular weight of 1211 daltons |
| 10/23/2003 | WO2002088717A3 Biopolymer marker having a molecular weight of 2056 daltons |
| 10/23/2003 | WO2002088716A3 Polymer marker having a molecular weight of 1518 daltons |
| 10/23/2003 | WO2002088712A3 Biopolymer marker state having a molecular weight of 1777 daltons |
| 10/23/2003 | WO2002088708A3 Biopolymer marker having a molecular weight of 1077 daltons |
| 10/23/2003 | WO2002088691A3 Device and method for the quantitative determination of nitrogen oxides in exhaled air and application thereof |
| 10/23/2003 | WO2002083708A3 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications |
| 10/23/2003 | WO2002077199A3 Methods and products related to fgf dimerization |
| 10/23/2003 | WO2002072759A3 Method to screen peptide display libraries using minicell display |
| 10/23/2003 | WO2002070730A3 Models and methods for determining systemic properties of regulated reaction networks |
| 10/23/2003 | WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 10/23/2003 | WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms |
| 10/23/2003 | WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 10/23/2003 | WO2002048404A3 Method and kit for enhancing the association rates of polynucleotides |
| 10/23/2003 | WO2002046384A3 Kinases and phosphatases sequences, and use thereof |
| 10/23/2003 | WO2002044336B1 Method of making a protein polymer and uses of the polymer |
| 10/23/2003 | WO2002044321A3 Rna interference mediating small rna molecules |
| 10/23/2003 | WO2002038811A3 Assay for the detection and quantitation of hemimethylation |
| 10/23/2003 | WO2002036617A3 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 10/23/2003 | WO2002034117A3 Multiple epitopes connected by a carrier |
| 10/23/2003 | WO2002032303A8 Glucose measurement utilizing non-invasive assessment methods |
| 10/23/2003 | WO2002028507A3 Electronic detection of interaction based on the interruption of flow |
| 10/23/2003 | WO2002020838A3 Method and system for detecting nucleic acids |
| 10/23/2003 | WO2002016943A3 Differential immunoassay |
| 10/23/2003 | WO2002001225A3 Tandem signaling assay |
| 10/23/2003 | WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 10/23/2003 | WO2001068805A3 Human olfactory receptors and genes encoding same |
| 10/23/2003 | WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 10/23/2003 | WO2001040519A8 Methods for identifying modulators for balance related disorders |
| 10/23/2003 | WO2001036974A8 Flow matrix assay device with movable separating member |
| 10/23/2003 | WO2001027635A8 Multiwell scanner and scanning method |
| 10/23/2003 | WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 10/23/2003 | WO2001005427A8 Psca: prostate stem cell antigen and uses thereof |
| 10/23/2003 | WO2001002567A8 16405 receptor, a g-protein coupled receptor |
| 10/23/2003 | WO2001000879A8 Novel kinases and uses thereof |
| 10/23/2003 | WO2001000812A8 22012, a novel human carboxypeptidase |
| 10/23/2003 | WO2001000811A8 17867, a novel human aminopeptidase |
| 10/23/2003 | WO2000062074A8 Use of 13c-nmr to detect binding |
| 10/23/2003 | US20030200555 For Alzheimer's disease diagnosis, treatment |
| 10/23/2003 | US20030200033 High-throughput alignment methods for extension and discovery |
| 10/23/2003 | US20030200032 Determination of compatibility of a set chemical modifications with an amino-acid chain |
| 10/23/2003 | US20030199911 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199910 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199909 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199908 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199907 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199906 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199905 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199904 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199903 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199902 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199901 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199900 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199899 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199898 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199897 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199896 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199895 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199894 Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
| 10/23/2003 | US20030199893 Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| 10/23/2003 | US20030199803 Integrated automatic blood collection and processing unit |
| 10/23/2003 | US20030199791 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199790 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199789 Method and apparatus for penetrating tissue |
| 10/23/2003 | US20030199745 Methods and devices for removing interfering species |
| 10/23/2003 | US20030199743 Screening test and procedure using apocrine sweat |
| 10/23/2003 | US20030199739 Printing device for personal medical monitors |
| 10/23/2003 | US20030199685 Detects changes in the level and pattern of expression of the molecular markers in the cell- based sample |
| 10/23/2003 | US20030199679 Recombinant antibodies specific for TNF-alpha |
| 10/23/2003 | US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 10/23/2003 | US20030199671 For protein isolation and purification |
| 10/23/2003 | US20030199624 Conductive nanocomposite films |
| 10/23/2003 | US20030199589 Anticonvulsant and central nervous system-depressing bis (fluorophenyl) alkylamides and their uses |
| 10/23/2003 | US20030199577 For preparation of DNA chips and bio-chips, where fixation of desired molecules on surface and study of surface is easy; prepared by reacting amine groups of aminosilylated surface of substrate with novel carbamate compound |
| 10/23/2003 | US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products |
| 10/23/2003 | US20030199469 Contacting tumor cells with modulating agent and with an antitumor therapeutic agent known to cause apotosis; determining degree of apoptosis of tumor cells; comparing degree of apoptosis with degree of apoptosis of tumor cells |
| 10/23/2003 | US20030199462 Methods and compositions for regulating cellular signaling |
| 10/23/2003 | US20030199452 Antigenic peptides reacting with anti-ovary antibodies |
| 10/23/2003 | US20030199438 Method for identification of proteins from intracellular bacteria |
| 10/23/2003 | US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic |
| 10/23/2003 | US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199428 Identifying a thrombin generation time for a blood sample to assess risk of bleeding, to diagnose various disorders, and to monitor the effects of pharmaceutical and other treatments. |
| 10/23/2003 | US20030199423 ICAM-related protein |
| 10/23/2003 | US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides |
| 10/23/2003 | US20030199102 Test tray, kit and methods for bodily fluid testing for newborn screening by tandem mass spectrometry |
| 10/23/2003 | US20030199101 Iodide and pH buffer tablet packaged in air-tight plastic-lined metal foil envelope |
| 10/23/2003 | US20030199100 Method and system for detecting and recording submicron sized particles |
| 10/23/2003 | US20030199098 Advanced tool for the quantification uniformity within biological processes and conversions |
| 10/23/2003 | US20030199097 Measurements for a sample on the measuring surfaces of a substrate which makes it possible to simplify the control and construction of a measuring device, shorten the measuring period, make the measuring conditions constant with accuracy |
| 10/23/2003 | US20030199096 Apparatus and method for high throughput analysis of compound-membrane interactions |
| 10/23/2003 | US20030199094 Assays for beta-amyloid processing |
| 10/23/2003 | US20030199089 Membrane to membrane delivery |
| 10/23/2003 | US20030199088 Minicell-based gene therapy |
| 10/23/2003 | US20030199086 Useful for analysis of mechanisms of cell death following brain ischemia, screening anti-ischemic drugs |
| 10/23/2003 | US20030199082 A platform having multiple test wells, containing a 20-80% by weight of a thermoplastic or thermosetting polymer and about 20-80% by weight of a non-metallic, thermoconductive material; can be used for fluorescent immunoassays |